FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Working to Cut Ethylene Oxide Emissions

CDRH director Jeffrey Shuren describes Center efforts to help sterilization facilities to reduce ethylene oxide emissions into the environment.

Medical Devices

Juvderm Volux XC Approved for Jawline Shaping

FDA approves Allergan Aesthetics Juvderm Volux XC for improving jawline definition in adults over the age of 21 with moderate to severe loss of jawlin...

latest-news-card-1
Federal Register

E-submission Guide for Expedited Safety Reports

Federal Register notice: FDA makes available a draft guidance entitled Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies...

Human Drugs

FDA Approves Cimerli as Generic Lucentis

FDA approves Coherus Cimerli as an interchangeable generic version of Genentechs Lucentis for all five label indications.

FDA General

Looking at the FDA/Industry Revolving Door

A Grid news report uses Linkedin data to estimate how many former FDAers are now working in regulated companies and discusses the ethical issues raise...

latest-news-card-1
Human Drugs

Alnylam Pharmaceuticals Plans NDA for Patisiran

Alnylam Pharmaceuticals plans to file an NDA submission late this year for patisiran, indicated for treating transthyretin-mediated amyloidosis with c...

Federal Register

Panel To Review Amylyx ALS Drug

Federal Register notice: FDA announces a 9/7 Peripheral and Central Nervous System Drugs Advisory Committee meeting that will review Amylyx Pharmaceut...

Medical Devices

Glaukos 510(k) Cleared for Intraocular Pressure

FDA clears a Glaukos 510(k) for its iStent Infinite Trabecular Micro-Bypass System and its use in a standalone procedure to reduce elevated intraocula...

Medical Devices

False Claims Liability for Medical Device Off-Label Use

Attorney Keeley McCarty says a recent government suit against Promothesus Group demonstrates the government is willing to use the False Claims Act to ...

latest-news-card-1
Human Drugs

CGMP and Other Violations at DSP Skin Care

FDA warns Los Angeles, CA-based DSP Skin Care about CGMP and other violations, some repeated from 2018, in its manufacturing of finished drugs.